Contact Information: Contacts: David Gutierrez Dresner Corporate Services 312.780.7240 dgutierrez@dresnerco.com Gregg Pollack Dresner Partners 312.780.7207 gpollack@dresnerco.com Ejaz Elahi Dresner Partners 312.780.7256 eelahi@dresnerco.com
Dresner Partners Advises Haemoscope in Divestiture of Its TEG Thrombelastograph Hemostasis Analyzer Business
| Source: Dresner Partners
CHICAGO, IL--(Marketwire - November 20, 2007) - Dresner Partners, a leading NASD middle-market
investment bank, announced today that it acted as exclusive financial
advisor to Haemoscope Corporation in the divestiture of its TEG®
Thrombelastograph® Hemostasis Analyzer business. Late last month,
Haemonetics Corporation announced its intent to acquire the TEG business
from Haemoscope for $44 million in cash. The acquisition closed today.
Haemoscope Corporation is a provider of blood hemostasis monitoring
systems. The TEG system can predict a patient's risk of bleeding and
thrombotic complications. With this knowledge, surgeons can plan a
patient's treatment to support the best possible clinical outcome.
Improved clinical outcomes can lead to lower hospital costs through reduced
transfusion and related adverse effects, as well as shorter ICU and
hospital stays.
Eli Cohen, Haemoscope's Chairman and CEO, said, "The Dresner team
recognized the shareholder value that could be unlocked through the sale of
the TEG business to a strategic partner. The team structured a transaction
that was in the best interests of Haemoscope's employees, customers and
shareholders."
According to Gregg Pollack, managing director of Dresner Partners who
advised Haemoscope, "There is a great strategic fit between the TEG
business and Haemonetics' vision of being a global leader in blood
management solutions. We are pleased that we were able to facilitate this
highly synergistic transaction."
"Advising Haemoscope in this transaction exemplifies the capabilities of
our rapidly growing health care practice," said Steven M. Dresner,
president of Dresner Partners. "The principals of Haemoscope, Eli Cohen
and Gabe Raviv, have been important clients of our firm. This transaction
represents a significant milestone for the shareholders of Haemoscope,
while also providing a strong foundation for the development of exciting
new generations of product in the hemostasis marketplace."
About Dresner Partners
Dresner Partners is a NASD-registered, middle-market investment bank based
in Chicago, Illinois. Founded in 1991, Dresner Partners provides financial
advisory services to business owners and managers throughout the United
States, including institutional private placements of debt and equity,
merger & acquisition advisory, and valuation and strategic consulting. Its
affiliate company, Dresner Corporate Services, is a strategic
communications firm specializing in investor and public relations. More
information is available via the Internet at www.dresnerpartners.com.